TrialHeart and vessels2025

Efficacy and safety of the urate-lowering agent febuxostat in chronic heart failure patients with hyperuricemia: results from the LEAF-CHF study.

Takashi Yokota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.